Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 458-468
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.458
Table 1 Patient characteristics by intervention, n (%)
N = 376
ESD (n = 122)
Knife-assisted endoscopic resection (n = 44)
EMR (n = 216)
P value
Mean age (mean ± SD)66.9 (11.8)64.5 (11.8)66 (9.7)0.452
Male (%)78 (63.9)23 (52.3)130 (60.2)0.395
Race/Ethnicity0.113
White78 (63.9)28 (63.6)144 (66.7)
Asian19 (15.6)6 (13.6)12 (5.6)
African American4 (3.3)1 (2.3)11 (5.1)
Latino14 (11.5)6 (13.6)25 (11.6)
Other7 (5.7)3 (6.8)24 (11.1)
Sedation< 0.001
General anesthesia11 (9.0)2 (4.5)7 (3.2)
Monitored anesthesia care93 (76.2)29 (65.9)117 (54.2)
Moderate sedation17 (13.9)13 (29.5)82 (38.0)
None1 (0.8)0 (0.0)10 (4.6)
Adequate bowel preparation121 (99.2)41 (93.2)210 (97.2)0.100
Table 2 Characteristics of polyp with follow-up, by intervention, n (%)
N = 287
ESD (n = 77)
Knife-assisted endoscopic resection (n = 32)
EMR (n = 178)
P value
Size of polyp, mm (mean ± SD)37.2 (19.7)32.7 (8.7)31.4 (11.5)0.010
En bloc69 (89.7)8 (25.0)27 (15.2)< 0.001
Location of polyp< 0.001
Cecum10 (13.0)7 (21.9)47 (26.4)
Ascending13 (16.9)12 (37.5)63 (35.4)
Transverse8 (10.4)6 (18.8)45 (25.3)
Descending2 (2.6)4 (12.5)12 (6.7)
Sigmoid10 (13.0)1 (3.1)5 (2.8)
Rectum34 (44.2)2 (6.3)6 (3.4)
Paris classification< 0.001
Is57 (74.0)18 (56.3)64 (36.0)
IIa16 (20.8)9 (28.1)102 (57.3)
IIb0 (0.0)1 (3.1)2 (1.1)
IIa+c2 (2.6)1 (3.1)2 (1.1)
IIc0 (0.0)1 (3.1)0 (0.0)
Isp2 (2.6)2 (6.3)8 (4.5)
Pathology< 0.001
Non-neoplastic0 (0.0)1 (3.1)10 (5.6)
Neoplastic, no high-grade dysplasia50 (64.9)25 (78.1)152 (85.4)
High-grade dysplasia17 (22.1)6 (18.8)12 (6.7)
Cancer10 (13.0)0 (0.0)4 (2.2)
First follow-up, days (mean ± SD)456.8 (326.1)365.0 (230.2)516.2 (377.7)0.061
Recurrence1 (1.3)0 (0.0)23 (12.9)0.0017
Complete resection< 0.001
R057 (74.0)6 (18.8)8 (4.5)
R118 (23.4)26 (81.3) 156 (87.6)
Rx2 (2.6)0 (0.0)14 (7.9)
Table 3 Comparison of recurrence with no recurrence

Recurrence, n (%)
No recurrence, n (%)
P value
Size of polyp, mm (mean ± SD)37.4 (17.1) 32.7 (13.8)0.202
Procedure0.002
ESD1/24 (4.2) 76/263 (28.9)
Knife-assisted endoscopic removal0/24 (0.0)32/263 (12.2)
EMR23/24 (95.8)155/263 (58.9)
En bloc resection0.003
En bloc2/24 (8.3)102/263 (38.8)
Non en bloc22/24 (91.7)161/263 (61.2)
Circumferential incision0.001
Yes1/99 (1.0)98/99 (99.0)
No23/188 (12.2)165/188 (87.8)
Prior resection0.154
Prior attempt3/24 (12.5) (17.6)14/263 (5.3)
No prior attempt21/24 (87.5)249/263 (94.7)
Pathology0.691
Non-neoplastic0/24 (0.0)11/263 (4.2)
Neoplastic, no high-grade dysplasia19/24 (79.2)208/263 (79.1)
High-grade dysplasia4/24 (16.7)31/263 (11.8)
Cancer1/24 (4.2)13/263 (4.9)
First follow-up, days (mean ± SD)498.0 (406.9)482.0 (348.7)0.854
Complete resection0.041
R01/24 (4.2)70/263 (26.6)
R122/24 (91.7)178/263 (67.7)
Rx1/24 (4.2)15/263 (5.7)
Table 4 Patient complications, n (%)
N = 376
ESD (n = 122)
Knife-assisted endoscopic resection (n = 44)
EMR (n = 216)
Complication8 (6.6)3 (6.8)14 (6.5)
Bleeding without intervention3 (2.5)11 (2.3)15 (2.3)
Bleeding with intervention3 (2.5)1 (2.3)1 (0.5)
SBO/partial SBO0 (0.0)0 (0.0)2 (0.9)
Bowel perforation2 (1.6)1 (2.3)0 (0.0)
Abdominal pain1 (0.8)11 (2.3)13 (1.4)
Unrelated complication0 (0.0)0 (0.0)3 (1.4)
Table 5 Univariate Cox regression evaluating predictors of recurrence, including endoscopic submucosal dissection versus endoscopic mucosal resection
Covariates
Unadjusted hazard ratio (95%CI)
P value
Treatment type0.041
EMR, pureReference
ESD, pure 0.12 (0.02-0.92)
Age, per year1.04 (0.99-1.08)0.109
Sex0.898
FemaleReference
Male1.06 (0.46-2.40)
Race0.139
WhiteReference
Non-White1.85 (0.82-4.19)
Polyp location0.376
Non-rectumReference
Rectum0.52 (0.12-2.22)
Prior resection attempt2.65 (0.76-9.29)0.127
Polyp size, by mm1.03 (1.01-1.05)0.001
Presence of circumferential incision0.12 (0.02-0.92)0.041
En bloc resection0.15 (0.03-0.63)0.010
JNET classification
Type 1Reference
Type 2A3.07 (0.41-22.92)0.273
Type 2B or 34.57 (0.41-50.74)0.216
R0 resection0.13 (0.02-0.93)0.042
Table 6 Multivariate Cox regression evaluating predictors of recurrence
Covariates
Adjusted hazard ratio (95%CI)
P value
Treatment type0.014
EMR, pureReference
ESD, pure 0.06 (0.01-0.57)
Polyp size, by mm1.05 (1.02-1.07)< 0.001